Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_assertion type Assertion NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_head.
- NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_provenance.
- NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_assertion evidence source_evidence_literature NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_provenance.
- NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_assertion SIO_000772 14583782 NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_provenance.
- NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_assertion wasDerivedFrom befree-2016 NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_provenance.
- NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_assertion wasGeneratedBy ECO_0000203 NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_provenance.